302 related articles for article (PubMed ID: 26403494)
1. Structure and function of legumain in health and disease.
Dall E; Brandstetter H
Biochimie; 2016 Mar; 122():126-50. PubMed ID: 26403494
[TBL] [Abstract][Full Text] [Related]
2. Mammalian legumain - A lysosomal cysteine protease with extracellular functions?
Lunde NN; Bosnjak T; Solberg R; Johansen HT
Biochimie; 2019 Nov; 166():77-83. PubMed ID: 31181234
[TBL] [Abstract][Full Text] [Related]
3. Structure and mechanism of an aspartimide-dependent peptide ligase in human legumain.
Dall E; Fegg JC; Briza P; Brandstetter H
Angew Chem Int Ed Engl; 2015 Mar; 54(10):2917-21. PubMed ID: 25630877
[TBL] [Abstract][Full Text] [Related]
4. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.
Sexton KB; Witte MD; Blum G; Bogyo M
Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs.
Poreba M
Biol Chem; 2019 Nov; 400(12):1529-1550. PubMed ID: 31021817
[TBL] [Abstract][Full Text] [Related]
6. Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile.
Dall E; Brandstetter H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jan; 68(Pt 1):24-31. PubMed ID: 22232165
[TBL] [Abstract][Full Text] [Related]
7. The Mammalian Cysteine Protease Legumain in Health and Disease.
Solberg R; Lunde NN; Forbord KM; Okla M; Kassem M; Jafari A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555634
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
Lee J; Bogyo M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
[TBL] [Abstract][Full Text] [Related]
9. Characterization of legumain.
Schwarz G; Brandenburg J; Reich M; Burster T; Driessen C; Kalbacher H
Biol Chem; 2002 Nov; 383(11):1813-6. PubMed ID: 12530547
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of Plant Legumain Reveals a Unique Two-Chain State with pH-Dependent Activity Regulation.
Zauner FB; Dall E; Regl C; Grassi L; Huber CG; Cabrele C; Brandstetter H
Plant Cell; 2018 Mar; 30(3):686-699. PubMed ID: 29453229
[TBL] [Abstract][Full Text] [Related]
11. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
[TBL] [Abstract][Full Text] [Related]
12. The Peptide Ligase Activity of Human Legumain Depends on Fold Stabilization and Balanced Substrate Affinities.
Dall E; Stanojlovic V; Demir F; Briza P; Dahms SO; Huesgen PF; Cabrele C; Brandstetter H
ACS Catal; 2021 Oct; 11(19):11885-11896. PubMed ID: 34621593
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.
Dall E; Brandstetter H
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):10940-5. PubMed ID: 23776206
[TBL] [Abstract][Full Text] [Related]
14. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R
Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879
[TBL] [Abstract][Full Text] [Related]
15. Nuclear legumain activity in colorectal cancer.
Haugen MH; Johansen HT; Pettersen SJ; Solberg R; Brix K; Flatmark K; Maelandsmo GM
PLoS One; 2013; 8(1):e52980. PubMed ID: 23326369
[TBL] [Abstract][Full Text] [Related]
16. Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.
Wang L; Chen S; Zhang M; Li N; Chen Y; Su W; Liu Y; Lu D; Li S; Yang Y; Li Z; Stupack D; Qu P; Hu H; Xiang R
J Cell Biochem; 2012 Aug; 113(8):2679-86. PubMed ID: 22441772
[TBL] [Abstract][Full Text] [Related]
17. Vacuolar processing enzyme in plant programmed cell death.
Hatsugai N; Yamada K; Goto-Yamada S; Hara-Nishimura I
Front Plant Sci; 2015; 6():234. PubMed ID: 25914711
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.
Lunde NN; Haugen MH; Bodin Larsen KB; Damgaard I; Pettersen SJ; Kasem R; Rut W; Drag M; Poreba M; Johansen HT; Solberg R
Biochimie; 2017 Aug; 139():27-37. PubMed ID: 28528272
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.
Brix K; McInnes J; Al-Hashimi A; Rehders M; Tamhane T; Haugen MH
Protoplasma; 2015 May; 252(3):755-74. PubMed ID: 25398648
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
